Embecta Revenue Growth Rates (EMBC), Current and Historic Growth - CSIMarket
CSIMarket
 


Embecta Corp   (NASDAQ: EMBC)
 

EMBC's Revenue Growth by Quarter and Year

Embecta 's Revenue results by quarter and year




EMBC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter September -
3rd Quarter June 271.70
2nd Quarter March 221.80
1st Quarter December 260.70
FY 754.20





EMBC Revenue third quarter 2026 Y/Y Growth Comment
Embecta Corp reported decrease in Revenue in the third quarter 2026 by -7.93% to $ 271.70 millions, from the same quarter in 2025.
The decrease in the third quarter 2026 Embecta Corp 's Revenue compares unfavorably to the Company's average Revenue decrease of -7.66%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 120 other companies have achieved higher Revenue growth. While Embecta Corp ' s Revenue decline of -7.93% ranks overall at the positon no. 2250 in the third quarter 2026.




EMBC Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter September - -7.43 % 1.85 % 2.55 %
3rd Quarter June -7.93 % 8.45 % -4.69 % -1.92 %
2nd Quarter March -14.06 % -9.88 % 3.36 % 0.95 %
1st Quarter December -0.15 % -5.71 % 0.44 % -4.7 %
FY   - -3.78 % 0.21 % -

Financial Statements
Embecta 's third quarter 2026 Revenue $ 271.70 millions EMBC's Income Statement
Embecta 's third quarter 2025 Revenue $ 295.10 millions Quarterly EMBC's Income Statement


EMBC Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter September - -10.03 % 5.4 % -1.37 %
3rd Quarter June 22.5 % 14.34 % -4.99 % 3.03 %
2nd Quarter March -14.92 % -1.15 % 3.43 % 0.51 %
1st Quarter December -1.81 % -8.96 % -1.67 % 0.4 %
FY (Year on Year)   - -3.78 % 0.21 % -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #121
Healthcare Sector #326
Overall #2250

Revenue Y/Y Growth Statistics
High Average Low
0.21 % -7.66 % -20.34 %
(Sep 30 2024)   (Jun 30 2024)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #121
Healthcare Sector #326
Overall #2250
Revenue Y/Y Growth Statistics
High Average Low
0.21 % -7.66 % -20.34 %
(Sep 30 2024)   (Jun 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Embecta 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
98.68 % 2.34 % -50.64 %
(Sep 30 2021)  


EMBC's III. Quarter Q/Q Revenue Comment
Embecta Corp achieved in the III. Quarter 2026 above company average sequential Revenue jump of 22.5%, to $ 271.70 millions, from $221.80 millions in the second quarter.
EMBC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Embecta 's Revenue growth quarter on quarter, overall rank is 461.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #96
Overall #461
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #96
Overall #461
Revenue Q/Q Growth Statistics
High Average Low
98.68 % 2.34 % -50.64 %
(Sep 30 2021)  


EMBC's III. Quarter Q/Q Revenue Comment
Embecta Corp achieved in the III. Quarter 2026 above company average sequential Revenue jump of 22.5%, to $ 271.70 millions, from $221.80 millions in the second quarter.
EMBC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Embecta 's Revenue growth quarter on quarter, overall rank is 461.


Embecta 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1,019.70 $ 1,043.10 $ 1,079.40 $ 1,079.80 $ 1,101.10
Y / Y Revenue Growth (TTM) -7.39 % -3.25 % -2.44 % -3.78 % -1.42 %
Year on Year Revenue Growth Overall Ranking # 2765 # 2669 # 1825 # 2762 # 2895
Seqeuential Revenue Change (TTM) -2.24 % -3.36 % -0.04 % -1.93 % 2.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 2414 # 2551 # 1802 # 2105 # 1975


Cumulative Revenue growth Comment
Embecta 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.39% year on year, at Jun 30 2026 compare to the -3.25% decrease at Mar 31 2026. If the Embecta 's fiscal year would end at Jun 30 2026, annual Revenue would be $1,020 millions.

In the Healthcare sector 389 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2669 to 2765.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 390
Overall # 2765

Revenue TTM Y/Y Growth Statistics
High Average Low
1.06 %
-7.11 %
-23.28 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 128
Sector # 346
S&P 500 # 2414
Cumulative Revenue growth Comment
Embecta 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.39% year on year, at Jun 30 2026 compare to the -3.25% decrease at Mar 31 2026. If the Embecta 's fiscal year would end at Jun 30 2026, annual Revenue would be $1,020 millions.

In the Healthcare sector 389 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2669 to 2765.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 390
Overall # 2765

Revenue TTM Y/Y Growth Statistics
High Average Low
1.06 %
-7.11 %
-23.28 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 128
Sector # 346
S&P 500 # 2414




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EMBC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Embecta Revenue Growth Rates (EMBC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Embecta Corp (CIK 1872789).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001872789-26-000033
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Embecta Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.